Results 261 to 270 of about 95,168 (297)
Some of the next articles are maybe not open access.
Designing spatial and temporal control of vaccine responses
Nature Reviews Materials, 2021Shih Hao Ou, Wei Luo, Bali Pulendran
exaly
1999
Hepatitis B virus (HBV) chronically infects 200–300 million people worldwide. The resulting acute and chronic disease that results from contact with these individuals or their blood is a leading cause of liver disease, including hepatocellular carcinoma, and mortality. In fact, HBV is second only to smoking as a cause of human cancers (1).
openaire +1 more source
Hepatitis B virus (HBV) chronically infects 200–300 million people worldwide. The resulting acute and chronic disease that results from contact with these individuals or their blood is a leading cause of liver disease, including hepatocellular carcinoma, and mortality. In fact, HBV is second only to smoking as a cause of human cancers (1).
openaire +1 more source
SARS-CoV-2 variants, spike mutations and immune escape
Nature Reviews Microbiology, 2021William T Harvey +2 more
exaly
Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation
Ca-A Cancer Journal for Clinicians, 2020Robert A Smith
exaly
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Nature Reviews Clinical Oncology, 2021Aakash Desai +2 more
exaly
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Nature Reviews Clinical Oncology, 2021Patrick A Ott
exaly